The Sir Dorabji Tata Trust (SDTT), the largest of the Tata Trusts, on Friday unanimously approved a ₹50 crore grant for Pune-based Jehangir Hospital, chaired by Jehangir H C Jehangir, who is also a trustee of the Sir Ratan Tata Trust (SRTT).
The approval came amid continuing differences over governance within the Tata Trusts and ahead of a crucial Tata Sons board meeting scheduled for November 26.
All five SDTT trustees — chairman Noel Tata, Venu Srinivasan, Vijay Singh, Neville Tata and Bhaskar Bhat — approved the proposal, according to people familiar with the development.
The grant formed part of a larger package of philanthropic funding approved during the meeting. The trust cleared five proposals involving total grants estimated at ₹150 crore to ₹200 crore.
𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐩𝐥𝐚𝐧𝐬 ₹𝟑𝟎𝟎 𝐜𝐫𝐨𝐫𝐞 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧
The ₹50 crore allocation is intended to support the expansion of Jehangir Hospital, a 350-bed multispeciality healthcare institution operated by the Cowasji Jehangir Trust.
Hospital representatives presented details of an expansion project estimated at more than ₹300 crore, which includes the construction of an additional building.
According to people familiar with the discussions, approximately one-fourth of the hospital's beds are reserved for subsidised treatment.
The trustees reportedly considered the hospital's plans to expand healthcare infrastructure and its efforts to raise resources without relying on private equity investment.
The remaining grants approved at the meeting included funding for a sports academy, poverty alleviation initiatives and programmes supporting girls. Several of the projects are located in economically disadvantaged regions.
𝐆𝐫𝐚𝐧𝐭 𝐫𝐚𝐢𝐬𝐞𝐬 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬
The funding decision attracted scrutiny because Jehangir, who chairs the hospital, also serves as a trustee of SRTT, another major shareholder of Tata Sons.
A person familiar with the matter had earlier alleged that the proposed grant was intended to secure Jehangir's support in decisions expected to arise within the Tata group in the coming weeks.
However, the allegation remains unverified, and no evidence establishing a connection between the grant and any voting arrangement has been made public.
Another person familiar with the trust's deliberations rejected concerns about a potential conflict of interest, maintaining that the grant did not involve any such conflict.
Questions had also been raised over the hospital's eligibility for charitable funding. Although Jehangir Hospital is registered in Maharashtra's charitable-hospital records, that registration alone does not establish whether all its services are provided free or at subsidised rates.
𝐆𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐝𝐢𝐬𝐩𝐮𝐭𝐞 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐞𝐬
The approval comes against the backdrop of disagreements among Tata Trusts trustees over governance, appointments and their role in decisions concerning Tata Sons.
Trustee Venu Srinivasan recently approached the Maharashtra Charity Commissioner seeking an inquiry into governance issues at SDTT, including the appointment and status of trustees and decisions concerning the trust's administration.
SDTT subsequently submitted its response, contesting the governance-related complaints.
Meanwhile, SRTT remains barred from convening board meetings under an order of the Maharashtra Charity Commissioner.
The SRTT board comprises Noel Tata, Venu Srinivasan, Jimmy N Tata and Jehangir H C Jehangir.
Together, the Tata Trusts control approximately 66 per cent of Tata Sons, giving their trustees considerable influence over the holding company's major decisions.
𝐓𝐚𝐭𝐚 𝐒𝐨𝐧𝐬 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 𝐨𝐧 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟔
The latest developments come ahead of the November 26 Tata Sons board meeting, where the company's proposed stock market listing and an alternative restructuring plan are expected to be discussed.
The listing issue has emerged as a major point of disagreement within the group, particularly over the implications of the Reserve Bank of India's regulatory requirements for upper-layer non-banking financial companies.
At the September 17 Tata Sons board meeting, directors had backed proposals concerning chairman N Chandrasekaran's reappointment and compliance with the regulatory listing requirement, while Noel Tata opposed the decisions.
Sources familiar with Friday's SDTT meeting said the proposed listing and other contentious governance matters were not formally discussed during the proceedings.
However, trustees reportedly held a brief private discussion lasting around 10 minutes after other attendees left the room.
The unanimous approval of the hospital grant comes at a sensitive time for the Tata group, with disagreements over governance, ownership and the future structure of Tata Sons continuing ahead of next week's board meeting.